The lung is the main affected organ in severe coronavirus disease 2019 (COVID-19) caused
by the novel coronavirus SARS-CoV-2, and lung damage is the leading cause of death in …

Background The histomorphological changes of lung damage in severe coronavirus
disease 2019 (COVID-19) have not yet been adequately characterized. In this article, we …

The pandemia of coronavirus disease 2019 (COVID-19) has caused more than 355,000
confirmed deaths worldwide. However, publications on postmortem findings are scarce. We …

Since December 2019, the global burden of the COVID-19 pandemic has increased rapidly
and has impacted nearly every country in the world, affecting those who are elderly or with …

Background Pulmonary involvement in COVID-19 is characterized pathologically by diffuse
alveolar damage (DAD) and thrombosis, leading to the clinical picture of Acute Respiratory …

The heterogeneity of fatal cases-persistence of viral infection in lung, clearance of virus but
severe lung injury, thrombosis, and exaggerated immune response–suggest that antiviral …

Abstract SARS-CoV-2, the etiologic agent of COVID-19, is a global pandemic with
substantial mortality dominated by acute respiratory distress syndrome. We systematically …

Objectives Current knowledge of the pulmonary pathology of coronavirus disease 2019
(COVID-19) is based largely on postmortem studies. In most, the interval between disease …

Sparse literature is available regarding autopsy findings of coronavirus disease 2019
(COVID-19) despite high mortality due to its highly contagious nature and lack of robust …

Since the outbreak of the COVID-19 pandemic, much has been learned regarding its clinical
course, prognostic inflammatory markers, disease complications, and mechanical ventilation …